FDA approves blood test method for colon cancer screening

The FDA approved Guardant Health's Shield blood test for colon cancer screening, making it likely to be covered by Medicare and private insurers. It is effective at detecting later-stage cancers but not early-stage polyps. A positive result requires follow-up with a colonoscopy. Doctors see potential for increased screening rates, but its impact on reducing mortality remains to be seen.

from World News Headlines, Latest International News, World Breaking News - Times of India https://ift.tt/6huqKdm
via

Comments

Popular posts from this blog

'Lying Liz'? Did Donald Trump call for Liz Cheney's execution? Here's the truth

New Jersey man pleads guilty to murdering and dismembering two women: Faces 40 years in prison